Eupraxia Pharmaceuticals Inc.

NasdaqCM:EPRX Stock Report

Market Cap: US$125.1m

Eupraxia Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:EPRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Sep 24BuyUS$5,139Michael WilminkIndividual1,900US$2.73
28 Jun 24BuyUS$37,848John MontalbanoIndividual14,800US$2.56
17 Jun 24BuyUS$2,926Michael WilminkIndividual1,100US$2.66
11 Jun 24BuyUS$2,248Michael WilminkIndividual800US$2.81
07 Jun 24BuyUS$2,730Michael WilminkIndividual1,000US$2.73
10 May 24BuyUS$1,920Michael WilminkIndividual640US$3.00

Insider Trading Volume

Insider Buying: EPRX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EPRX?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,864,8685.24%
Hedge Funds2,784,0497.82%
Individual Insiders7,263,77420.4%
General Public23,709,86266.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.7%.

Top Shareholders

Top 23 shareholders own 33.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.68%
Robert Disbrow
3,092,500US$10.9m0%no data
7.82%
Manchester Management Company, LLC
2,784,049US$9.8m0%21.15%
4.21%
Joseph Freedman
1,501,200US$5.3m0%no data
3.92%
Scotiabank Global Banking and Markets, Asset Management Division
1,396,281US$4.9m2.14%0.03%
3.4%
John Montalbano
1,212,466US$4.3m0%no data
1.89%
James Helliwell
674,012US$2.4m0%no data
0.96%
Paul Geyer
340,346US$1.2m0%no data
0.63%
Michael Wilmink
224,865US$789.9k0.85%no data
0.41%
RBC Dominion Securities Inc., Asset Management Arm
146,287US$513.9k3.94%no data
0.35%
RBC Private Counsel (USA) Inc.
125,000US$439.1k0%0.01%
0.32%
Bruce Cousins
114,286US$401.5k0%no data
0.18%
Ninepoint Partners LP
65,900US$231.5k0%0.01%
0.14%
BMO Asset Management Corp.
49,250US$173.0k0%no data
0.13%
Amanda Malone
46,343US$162.8k0%no data
0.097%
Goldman Sachs Group, Investment Banking and Securities Investments
34,500US$121.2k0%no data
0.093%
UBS Asset Management AG
33,000US$115.9k11.5%no data
0.076%
Paul Brennan
27,200US$95.6k0%no data
0.039%
Richard Glickman
13,930US$48.9k0%no data
0.036%
180 Wealth Advisors, LLC
13,000US$45.7k0%0.01%
0.024%
Simon Pimstone
8,626US$30.3k0%no data
0.022%
Mark Kowalski
8,000US$28.1k0%no data
0.0042%
Toronto-Dominion Bank, Banking Investments
1,500US$5.3k0%no data
0.00042%
National Bank Investments Inc.
150US$525.60%no data